Co-Authors
This is a "connection" page, showing publications co-authored by Solange Peters and Marina Garassino.
Connection Strength
1.430
-
OncoAlert Round Table Discussions: The Global COVID-19 Experience. JCO Glob Oncol. 2021 04; 7:455-463.
Score: 0.234
-
Severity of COVID-19 in patients with lung cancer: evidence and challenges. J Immunother Cancer. 2021 03; 9(3).
Score: 0.233
-
COVID-19 in patients with thoracic malignancies (TERAVOLT): first results of an international, registry-based, cohort study. Lancet Oncol. 2020 07; 21(7):914-922.
Score: 0.222
-
Report on the status of women occupying leadership roles in oncology. ESMO Open. 2018; 3(6):e000423.
Score: 0.197
-
Gender-related challenges facing oncologists: the results of the ESMO Women for Oncology Committee survey. ESMO Open. 2018; 3(6):e000422.
Score: 0.197
-
Phase II Trial of Atezolizumab As First-Line or Subsequent Therapy for Patients With Programmed Death-Ligand 1-Selected Advanced Non-Small-Cell Lung Cancer (BIRCH). J Clin Oncol. 2017 Aug 20; 35(24):2781-2789.
Score: 0.180
-
Supporting Clinical Decision-Making during the SARS-CoV-2 Pandemic through a Global Research Commitment: The TERAVOLT Experience. Cancer Cell. 2020 11 09; 38(5):602-604.
Score: 0.057
-
TERAVOLT: Thoracic Cancers International COVID-19 Collaboration. Cancer Cell. 2020 06 08; 37(6):742-745.
Score: 0.055
-
Treatment Guidance for Patients With Lung Cancer During the Coronavirus 2019 Pandemic. J Thorac Oncol. 2020 07; 15(7):1119-1136.
Score: 0.055